An interventional study of Physical Activity in Cardiovascular Risk Factor, Sedentary Lifestyle and Physical Activity, sponsored by Kent State University. Completed. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-12-28.
Sponsored by Kent State University · Not applicable, Interventional, and Prevention
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university.
This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System.
Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary.
Exclusion Criteria:
Participants were subjected to a 12-week exercise program targeting the federal physical activity guidelines.
Behavioral: Physical Activity
Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week).
Height
Objectively measured height in meters using a standard clinical stadiometer.
Time frame: Assessed once at baseline.
Weight
Objectively measured weight in kilograms using a standard clinical scale.
Time frame: Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up.
Systolic Blood Pressure
Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.
Time frame: Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
Diastolic Blood Pressure
Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer.
Time frame: Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.
High-Density Lipoprotein
Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit.
Time frame: Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Low-Density Lipoprotein
Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit.
Time frame: Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.
Total Serum Cholesteral
Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit.
Time frame: Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up.
Impaired Fasting Glucose
Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit.
Time frame: Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up.
Accelerometer-Based Physical Activity
Assessment of accelerometer-based physical activity outcome measures (e.g., steps per day).
Time frame: Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs.
Sleep Quality (Pittsburgh Sleep Quality Index)
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.
Time frame: Change from baseline sleep quality at 4-weeks, 8-weeks, and 12-weeks follow-up.
Depression (Depression, Anxiety, and Stress Scale-21)
The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.
Time frame: Change from baseline depression at 4-weeks, 8-weeks, and 12-weeks follow-up.
Anxiety (Depression, Anxiety, and Stress Scale-21)
The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.
Time frame: Change from baseline anxiety at 4-weeks, 8-weeks, and 12-weeks follow-up.
Stress (Depression, Anxiety, and Stress Scale-21)
The depression, anxiety, and stress scale-21 (DASS-21) is a clinical assessment that measures the three related states of depression, anxiety and stress.
Time frame: Change from baseline stress at 4-weeks, 8-weeks, and 12-weeks follow-up.
Mood (Profile of Mood States)
The Profile of Mood States (POMS) is a psychological rating scale used to assess transient, distinct mood states.
Time frame: Change from baseline mood at 4-weeks, 8-weeks, and 12-weeks follow-up.
Quality of Life (36-Item Short Form Survey)
The 36-item short form survey (SF-36) is a set of generic, coherent, and easily administered quality-of-life measures.
Time frame: Change from baseline quality of life at 4-weeks, 8-weeks, and 12-weeks follow-up.
No study locations are listed for this record.
Plan to share: No
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kent State University